14-50445164-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_006575.6(MAP4K5):āc.1216T>Cā(p.Phe406Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000917 in 1,613,382 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_006575.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP4K5 | NM_006575.6 | c.1216T>C | p.Phe406Leu | missense_variant | 18/33 | ENST00000682126.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP4K5 | ENST00000682126.1 | c.1216T>C | p.Phe406Leu | missense_variant | 18/33 | NM_006575.6 | P1 | ||
MAP4K5 | ENST00000013125.9 | c.1216T>C | p.Phe406Leu | missense_variant | 18/33 | 1 | P1 | ||
MAP4K5 | ENST00000554990.6 | n.1969T>C | non_coding_transcript_exon_variant | 4/19 | 2 | ||||
MAP4K5 | ENST00000557390.6 | c.1216T>C | p.Phe406Leu | missense_variant, NMD_transcript_variant | 18/33 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000524 AC: 13AN: 248154Hom.: 0 AF XY: 0.0000371 AC XY: 5AN XY: 134644
GnomAD4 exome AF: 0.0000951 AC: 139AN: 1461184Hom.: 0 Cov.: 31 AF XY: 0.0000949 AC XY: 69AN XY: 726842
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74356
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at